| ²é¿´: 1601 | »Ø¸´: 22 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
ÕâÑùµÄDecision£¬ÎÄÕ»¹ÓоÈÂð£¿
|
|||
|
Thank you for submission of your paper to Cell Reports. I have included the comments that reviewers made on your paper, which I hope you will find useful and constructive. As you will see, the overall view is that the study is potentially interesting, but the recommendation is against publication of the paper in the current form in Cell Reports and we have therefore closed the submission. That said, the reviewers do make suggestions for further experiments and analyses that might guide the paper toward being a stronger candidate for the journal. In particular, we would need a more developed mechanism and more physiologically relevant system to consider publication in Cell Reports. If you are interested in pursuing further consideration of this work at Cell Reports, you would first need to submit a point-by-point response that outlines how you might be able to address the reviewer concerns, and outlines how any corresponding results and/or edits would be incorporated into a revised manuscript. We would then assess the plan for revision, possibly in consultation with the reviewers. Based on these considerations, we would either reactivate the manuscript file to enable resubmission, or reiterate our decision to reject the paper. I know that this outcome is disappointing, given the hard work that you and your colleagues have put into the paper. I hope that the reviewers' comments will be useful to you as you consider next steps, and I hope that you will consider Cell Reports for future submissions as your interesting work progresses. ¸÷·´ó¸ç£¬Ð¡µÜµÄÎÄÕ¸øµÄ½áÂÛÈçÉÏ£¬»¹ÓÐÏ£ÍûÂð£¿Í¶¸åϵͳÀïÃæÏÔʾrejectÁË£¬ÊDz»ÊÇÒѾûµÄ¾ÈÁË |
» ²ÂÄãϲ»¶
²ÄÁÏÓ뻯¹¤304Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
»¶Ó211±¾¿ÆÍ¬Ñ§£¬¹ýAÇø¹ú¼ÒÏߣ¬AÇø·ÇƫԶһ±¾£¬½»²æÑ§¿Æ¿ÎÌâ×é
ÒѾÓÐ19È˻ظ´
282Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
347Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
³É¹ûϵͳ·ÃÎÊÁ¿´ó£¬Çë15·ÖÖÓºóÔÙ³¢ÊÔ¡£Óɴ˸øÄúÔì³ÉµÄ²»±ã£¬¾´ÇëÁ½⡣
ÒѾÓÐ16È˻ظ´
080500²ÄÁÏ¿ÆÑ§Ó빤³Ì
ÒѾÓÐ10È˻ظ´
²ÄÁÏÀ࿼Ñе÷¼Á
ÒѾÓÐ8È˻ظ´
»¯Ñ§×¨Òµµ÷¼Á
ÒѾÓÐ3È˻ظ´
274»·¾³¹¤³ÌÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
±¾×ÓдÍêÁË£¬¸øDSÐֵܿ´ÁË£¬µÃÁË92·Ö
ÒѾÓÐ10È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
½Î÷ʦ´ó»¯Ñ§¹¤³ÌѧԺ2026ÕÐÊÕ»¯Ñ§»¯¹¤Ïà¹Øµ÷¼ÁÉú110+ÈË
+2/862
CSC¹ú¼Ò¹«ÅÉ-´´ÐÂÐÍÈ˲Źú¼ÊÅàÑøÏîÄ¿-ÿÄê7ÈË-ÐÂ¼ÓÆÂÄÏÑóÀí¹¤´óѧ-Î人´óѧ-УÄÚÑ¡°Î
+1/90
±±¾©ÐÅÏ¢¿Æ¼¼´óѧÁªºÏÇ廪´óѧij¹ú¼ÒÖØµãʵÑéÊÒ£¬ÁªºÏÅàÑøË¶Éú¡¢²©Éú£¬²¢³¤ÆÚÕв©Ê¿ºó
+1/87
ÄϾ©ÁÖÒµ´óѧ»¯¹¤ÔºÓÂÇ¿/Àµ³¿»¶½ÌÊÚÍŶÓÕÐÊÕÉêÇ뿼ºËÖÆ²©Ê¿
+1/84
ÄϾ©´óѧ-¹ãÖÝ´óѧÕÐÆ¸²©Ê¿ºó »¶Ó¹ã´óÓÅÐãÈ˲ţ¡£¡£¡
+1/82
°¬Àï¿¨ÌØ (Alicat) ±¾°²ia·À±¬ÐÍÖÊÁ¿Á÷Á¿¿ØÖÆÆ÷Ó¦ÓÃÓÚµç½âÖÆÇâ
+2/52
2026ÄêÇൺÀí¹¤´óѧůͨרҵ˶ʿÉúÕÐÉú_081404·½Ïò&0852·½Ïò
+2/44
Çൺ¿Æ¼¼´óѧɽ¶«Ê¡Á÷³ÌÄ£ÄâÓëÓÅ»¯ÖصãʵÑéÊÒ/ϵͳ¹¤³ÌÍŶÓÕÐÊÕ˶ʿÑо¿Éú£¬³ÏÑû¼ÓÈë
+1/36
¹ã¶«Ê¯ÓÍ»¯¹¤Ñ§ÔºÁõʫӽ½ÌÊÚÍŶӻ¯Ñ§»¯¹¤¡¢²ÄÁÏ¿ÆÑ§µÈ·½ÏòÉÐÓе÷¼ÁÃû¶î
+1/34
×ø±êÄϾ©»òÖܱ߸½½ü
+1/27
¡¾ÕÐÉúÆôÊ¡¿´óÁ¬Àí¹¤´óѧ¹¤³ÌÁ¦Ñ§ÏµÑо¿ÉúÕÐÉú
+1/19
»ªÖпƼ¼´óѧţ¹ã´ï½ÌÊÚÕÐÆ¸²©Ê¿ºó
+1/18
ÖÐɽ´óѧ-ÏȽøÖÆÔìѧԺ-ÖÇÄÜÇý¶¯·½Ïò-ÕÐÊÕ2026Äê9ÔÂÈëѧ²©Ê¿Éú
+1/10
±±¾©º½¿Õº½Ìì´óѧ26¼¶²©Ê¿ÕÐÉú-ÉúÎïҽѧ¹¤³Ì-ºÏ³ÉÉúÎïѧ
+1/8
Æë³¹¤Òµ´óѧÇṤѧ²¿¡¢ÂÌÉ«ÔìÖ½Óë×ÊÔ´Ñ»·È«¹úÖØµãʵÑéÊÒÕÐÊÕÒ»Ö¾Ô¸»òµ÷¼ÁÑо¿Éú
+1/7
Analytical Science Advances£¨Wiley³ö°æÉ磩³¤ÆÚÕ÷¸åÖÐ..
+1/7
½ÌÓý²¿³¤½Ñ§Õߺʹ´ÐÂÍŶӷ¢Õ¹¼Æ»®¡±ÈëÑ¡ÍŶÓÕÐÊÕ ²ÄÁÏ£¬»¯Ñ§Ó뻯¹¤²©Ê¿Ñо¿Éú
+1/7
½ÓÊÜAÇø»·¾³×¨ÒµÀàµ÷¼Á
+1/5
¸÷λ´óÀУ¬ÃæÉÏÏîĿԤËã¶àÉÙºÏÊÊ£¿Ô¤ËãÓÐÓÃÂð£¿
+1/4
26Äê²ÄÁÏ/»¯Ñ§Ïà¹Ø×¨Òµ²©Ê¿Ñо¿ÉúÕÐÉú ÎÂÖÝ´óѧ»¯Ñ§Óë²ÄÁϹ¤³ÌѧԺ(26ÄêÇï¼¾Èëѧ)
+1/1
14Â¥2021-05-31 11:45:19
2Â¥2021-05-31 10:23:11
3Â¥2021-05-31 10:23:59
4Â¥2021-05-31 10:26:17
¼òµ¥»Ø¸´
tzynew5Â¥
2021-05-31 10:31
»Ø¸´
×·ÇóÃεÄÈË(½ð±Ò+1): лл²ÎÓë
o ·¢×ÔСľ³æAndroid¿Í»§¶Ë
ìµêØ201912Â¥
2021-05-31 11:34
»Ø¸´
×·ÇóÃεÄÈË(½ð±Ò+1): лл²ÎÓë
¡£ ·¢×ÔСľ³æAndroid¿Í»§¶Ë
СÖíÅ寿0111Â¥
2021-05-31 11:27
»Ø¸´
ooll43219Â¥
2021-05-31 10:59
»Ø¸´













»Ø¸´´ËÂ¥